Display options
Cite
Kwiatkowski MA, Roberts BZ, van Enkhuizen J, et al. Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice. Eur Neuropsychopharmacol. 2020;42:75-86doi: 10.1016/j.euroneuro.2020.11.004.
Kwiatkowski, M. A., Roberts, B. Z., van Enkhuizen, J., Ji, B., Zhou, X., & Young, J. W. (2021). Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 4275-86. https://doi.org/10.1016/j.euroneuro.2020.11.004
Kwiatkowski, Molly A, et al. "Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 42 (2021): 75-86. doi: https://doi.org/10.1016/j.euroneuro.2020.11.004
Kwiatkowski MA, Roberts BZ, van Enkhuizen J, Ji B, Zhou X, Young JW. Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice. Eur Neuropsychopharmacol. 2021 Jan;42:75-86. doi: 10.1016/j.euroneuro.2020.11.004. Epub 2020 Nov 13. PMID: 33191077.
Copy Download .nbib Format: NLM
Share it on

Eur Neuropsychopharmacol. 2021 Jan;42:75-86. doi: 10.1016/j.euroneuro.2020.11.004. Epub 2020 Nov 13.

Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Molly A Kwiatkowski, Benjamin Z Roberts, Jordy van Enkhuizen, Baohu Ji, Xianjin Zhou, Jared W Young

Affiliations

  1. Department of Psychiatry, UC San Diego School of Medicine, University of California, San Diego, CA 92093-0804, United States.
  2. Department of Psychiatry, UC San Diego School of Medicine, University of California, San Diego, CA 92093-0804, United States; Research Service, VA San Diego Healthcare System, United States. Electronic address: [email protected].

PMID: 33191077 DOI: 10.1016/j.euroneuro.2020.11.004

Abstract

Bipolar disorder (BD) is a severe mental illness affecting 2% of the global population. Current pharmacotherapies provide incomplete symptom remediation, highlighting the need for novel therapeutics. BD is characterized by fluctuations between mania and depression, likely driven by shifts between hyperdopaminergia and hypercholinergia, respectively. Hyperdopaminergia may result from insufficient activity of the dopamine transporter (DAT), the primary mediator of synaptic dopamine clearance. The DAT knockdown (DAT KD) mouse recreates this mechanism and exhibits a highly reproducible hyperexploratory profile in the cross-species translatable Behavioral Pattern Monitor (BPM) that is: (a) consistent with that observed in BD mania patients; and (b) partially normalized by chronic lithium and valproate treatment. The DAT KD/BPM model of mania therefore exhibits high levels of face-, construct-, and predictive-validity for the pre-clinical assessment of putative anti-mania drugs. Three different drug regimens - chronic nicotine (nicotinic acetylcholine receptor (nAChR) agonist; 40 mg/kg/d, 26 d), subchronic suramin (anti-purinergic; 20 mg/kg, 1 × /wk, 4 wks), and subchronic resveratrol (striatal DAT upregulator; 20 mg/kg/d, 4 d) - were administered to separate cohorts of male and female DAT KD- and wildtype (WT) littermate mice, and exploration was assessed in the BPM. Throughout, DAT KD mice exhibited robust hyperexploratory profiles relative to WTs. Nicotine partially normalized this behavior. Resveratrol modestly upregulated DAT expression but did not normalize DAT KD behavior. These results support the mania-like profile of DAT KD mice, which may be partially remediated by nAChR agonists via restoration of disrupted catecholaminergic/cholinergic equilibrium. Delineating the precise mechanism of action of nicotine could identify more selective therapeutic targets.

Copyright © 2020. Published by Elsevier B.V.

Keywords: Bipolar Disorder; Dopamine transporter; Mania; Nicotine; Resveratrol; Suramin

Conflict of interest statement

Declaration of Competing Interest None.

Publication Types

Grant support